1. Home
  2. LUCY vs ACON Comparison

LUCY vs ACON Comparison

Compare LUCY & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innovative Eyewear Inc.

LUCY

Innovative Eyewear Inc.

HOLD

Current Price

$0.72

Market Cap

6.7M

Sector

Health Care

ML Signal

HOLD

Logo Aclarion Inc.

ACON

Aclarion Inc.

HOLD

Current Price

$2.28

Market Cap

7.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
LUCY
ACON
Founded
2017
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.7M
7.4M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
LUCY
ACON
Price
$0.72
$2.28
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
215.0K
41.1K
Earning Date
05-14-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
63.39
99.82
EPS
N/A
N/A
Revenue
$2,661,669.00
$75,730.00
Revenue This Year
$175.92
$87.22
Revenue Next Year
$205.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
62.65
65.62
52 Week Low
$0.65
$1.95
52 Week High
$2.24
$12.03

Technical Indicators

Market Signals
Indicator
LUCY
ACON
Relative Strength Index (RSI) 44.94 39.01
Support Level $0.66 $1.95
Resistance Level $1.17 $3.54
Average True Range (ATR) 0.06 0.17
MACD 0.00 0.03
Stochastic Oscillator 50.72 58.93

Price Performance

Historical Comparison
LUCY
ACON

About LUCY Innovative Eyewear Inc.

Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.

About ACON Aclarion Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.

Share on Social Networks: